Check-Cap Ltd. (CHEK)
NASDAQ: CHEK · Real-Time Price · USD
0.7469
-0.0021 (-0.28%)
Jul 25, 2025, 1:12 PM - Market open
Check-Cap Market Cap
Check-Cap has a market cap or net worth of $4.37 million as of July 25, 2025. Its market cap has decreased by -62.00% in one year.
Market Cap
4.37M
Enterprise Value
-13.44M
1-Year Change
-62.00%
Ranking
Category
Stock Price
$0.75
Market Cap Chart
Since March 4, 2015, Check-Cap's market cap has decreased from $33.40M to $4.37M, a decrease of -86.92%. That is a compound annual growth rate of -17.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2025 | 4.40M | -24.14% |
| Dec 31, 2024 | 5.80M | -52.46% |
| Dec 29, 2023 | 12.20M | -4.69% |
| Dec 30, 2022 | 12.80M | -80.31% |
| Dec 31, 2021 | 65.00M | 205.16% |
| Dec 31, 2020 | 21.30M | 131.52% |
| Dec 31, 2019 | 9.20M | 162.86% |
| Dec 31, 2018 | 3.50M | -73.48% |
| Dec 29, 2017 | 13.20M | -52.52% |
| Dec 30, 2016 | 27.80M | 167.31% |
| Dec 31, 2015 | 10.40M | -68.86% |
| Mar 4, 2015 | 33.40M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 723.06B |
| Johnson & Johnson | 407.97B |
| AbbVie | 337.08B |
| Novo Nordisk | 313.06B |
| UnitedHealth Group | 252.71B |
| AstraZeneca | 228.91B |
| Novartis AG | 227.81B |
| Abbott Laboratories | 218.59B |